Addressing acute coronary syndromes

New challenges and opportunities after the CANTOS trial (Canakinumab Anti-Inflammatory Thrombosis Outcomes Study)

Research output: Contribution to journalReview article

6 Citations (Scopus)
Original languageEnglish
Pages (from-to)1100-1102
Number of pages3
JournalCirculation
Volume137
Issue number11
DOIs
Publication statusPublished - Jan 1 2018

Keywords

  • Acute coronary syndrome
  • Biomarkers
  • Immune system
  • Immunomodulation
  • Physiopathology
  • Precision medicine

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

@article{7f04a287695c45ecadf8f9a09eac278b,
title = "Addressing acute coronary syndromes: New challenges and opportunities after the CANTOS trial (Canakinumab Anti-Inflammatory Thrombosis Outcomes Study)",
keywords = "Acute coronary syndrome, Biomarkers, Immune system, Immunomodulation, Physiopathology, Precision medicine",
author = "Filippo Crea and Giovanna Liuzzo",
year = "2018",
month = "1",
day = "1",
doi = "10.1161/CIRCULATIONAHA.117.032178",
language = "English",
volume = "137",
pages = "1100--1102",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Addressing acute coronary syndromes

T2 - New challenges and opportunities after the CANTOS trial (Canakinumab Anti-Inflammatory Thrombosis Outcomes Study)

AU - Crea, Filippo

AU - Liuzzo, Giovanna

PY - 2018/1/1

Y1 - 2018/1/1

KW - Acute coronary syndrome

KW - Biomarkers

KW - Immune system

KW - Immunomodulation

KW - Physiopathology

KW - Precision medicine

UR - http://www.scopus.com/inward/record.url?scp=85051720247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051720247&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.117.032178

DO - 10.1161/CIRCULATIONAHA.117.032178

M3 - Review article

VL - 137

SP - 1100

EP - 1102

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 11

ER -